Develops blood and plasma technologies that enhance the safety and effectiveness of transfusions and therapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CellPhire Therapeutics develops medical and biotechnology products focused on blood and plasma therapies. The company creates technologies for blood stabilization, processing, and transfusion to improve safety and effectiveness. Its platform supports healthcare providers and researchers in delivering advanced blood-based treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CellPhire Therapeutics Management Team
CellPhire Therapeutics Valuations & Financials
View real-time NPM data on CellPhire Therapeutics stock including daily CellPhire Therapeutics stock price estimates, valuation history, and historical share price information. Access CellPhire Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CellPhire Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on CellPhire Therapeutics? Get in touch to learn more.
Similar Companies
like CellPhire Therapeutics
Imbria Pharmaceuticals
Healthcare & Life Sciences
Develops therapies that improve cardiac energy metabolism to treat heart failure and related cardiometabolic diseases.
Coologics
Healthcare & Life Sciences
Develops drug-free cooling device technology for treating vaginal infections, offering sustainable alternatives to antibiotics for women's health.
Valora Therapeutics
Healthcare & Life Sciences
Decode interactions that guide immune communication via sugar codes to unlock immunotherapies with new targeting strategies.
Iris Telehealth
Healthcare & Life Sciences
Telepsychiatry services for community mental health systems.
Trusted
Healthcare & Life Sciences
Digital employment platform built by nurses for nurses.
Nutcracker Therapeutics
Healthcare & Life Sciences
Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.
FAQ
We have answers
CellPhire Therapeutics stock does not trade on public stock exchanges. CellPhire Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CellPhire Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CellPhire Therapeutics Stock does not trade on public stock exchanges. In order to sell CellPhire Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CellPhire Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CellPhire Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CellPhire Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CellPhire Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CellPhire Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CellPhire Therapeutics is a private company and has not had an IPO. There is currently no CellPhire Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CellPhire Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
